Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Ureteral Neoplasms 4 Neoplasm Metastasis 3 Urologic Neoplasms 2 Urogenital Neoplasms 2 Carcinoma, Renal Cell 2 Urologic Diseases 1 Urogenital Diseases 1 Urinary Bladder Diseases 1 Urachal adenocarcinoma 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Peripheral Nervous System Diseases 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Melanoma 1 Male Urogenital Diseases 1 Female Urogenital Diseases 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma, Adenoid Cystic 1 Breast Neoplasms 1 Advanced Bladder Cancer 1

Interventions

pembrolizumab 54 Nivolumab 50 Ipilimumab 28 Cyclophosphamide 16 binimetinib 10 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Radiosurgery 9 relatlimab 8 encorafenib 8 Opdualag 8 Biopsy 8 aldesleukin 7 Interleukin-2 7 atezolizumab 6 Immunotherapy 6 Blood Specimen Collection 6 cemiplimab 5 CTLA-4 Antigen 5 Bevacizumab 5 trametinib 4 fludarabine phosphate 4 dabrafenib 4 Temozolomide 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4 spartalizumab 3 Surgical Procedures, Operative 3 Metformin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × enfortumab vedotin × Clear all

NCT06906822 2025-09-18

PlugIN

Grupo Español Multidisciplinar de Melanoma

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡